Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy.
暂无分享,去创建一个
[1] D. Pennell,et al. Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction , 2017 .
[2] Amit R. Patel,et al. Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis. , 2017, JACC. Cardiovascular imaging.
[3] R. Chan,et al. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis. , 2016, JACC. Cardiovascular imaging.
[4] D. Andreini,et al. Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction: A Prospective Multicenter Study. , 2016, Journal of the American College of Cardiology.
[5] M. Mayr,et al. Native T1 and T2 mapping by CMR in lupus myocarditis: Disease recognition and response to treatment. , 2016, International journal of cardiology.
[6] Hans Eiskjær,et al. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.
[7] Amit R. Patel,et al. Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use. , 2016, International journal of cardiology.
[8] M. Schwab,et al. Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach , 2016, Journal of Cardiovascular Magnetic Resonance.
[9] S. Prabhu,et al. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy , 2016, Journal of cardiovascular electrophysiology.
[10] S. Grieve,et al. Prevalence, distribution and clinical correlates of myocardial fibrosis in systemic lupus erythematosus: a cardiac magnetic resonance study , 2016, Lupus.
[11] Amit R. Patel,et al. Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction , 2016, Circulation. Cardiovascular imaging.
[12] Jonathan R. Weir-McCall,et al. Left Ventricular Noncompaction Anatomical Phenotype or Distinct Cardiomyopathy ? , 2016 .
[13] E. Nagel,et al. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. , 2016, JACC. Cardiovascular imaging.
[14] E. Nagel,et al. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. , 2015, Circulation. Cardiovascular imaging.
[15] Pietro Delise,et al. Right Ventricular Strain and Dyssynchrony Assessment in Arrhythmogenic Right Ventricular Cardiomyopathy: Cardiac Magnetic Resonance Feature-Tracking Study , 2015, Circulation. Cardiovascular imaging.
[16] P. Kellman,et al. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2015, Circulation.
[17] N. Geller,et al. Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy. , 2015, American heart journal.
[18] C. Kramer. Role of Cardiac MR Imaging in Cardiomyopathies , 2015, The Journal of Nuclear Medicine.
[19] Barry J Maron,et al. New perspectives on the prevalence of hypertrophic cardiomyopathy. , 2015, Journal of the American College of Cardiology.
[20] B. Wong,et al. Myocardial Fibrosis Burden Predicts Left Ventricular Ejection Fraction and Is Associated With Age and Steroid Treatment Duration in Duchenne Muscular Dystrophy , 2015, Journal of the American Heart Association.
[21] S. Piechnik,et al. T1 mapping and survival in systemic light-chain amyloidosis , 2014, European heart journal.
[22] D. Kaye,et al. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. , 2015, European heart journal cardiovascular Imaging.
[23] S. K. White,et al. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance , 2014, Journal of Cardiovascular Magnetic Resonance.
[24] G. Kitas,et al. Heart failure imaging patterns in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance. , 2014, International journal of cardiology.
[25] Akshay S. Desai,et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.
[26] E. Cook,et al. Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy , 2014, Circulation.
[27] René M. Botnar,et al. Coronary Vessel Wall Contrast Enhancement Imaging as a Potential Direct Marker of Coronary Involvement , 2014, JACC. Cardiovascular imaging.
[28] V. Fuster,et al. The MOGE(S) classification of cardiomyopathy for clinicians. , 2014, Journal of the American College of Cardiology.
[29] D. Bluemke,et al. Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update , 2014, Journal of Cardiovascular Magnetic Resonance.
[30] Amit R. Patel,et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. , 2014, Heart rhythm.
[31] Karima Addetia,et al. Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias. , 2014, The American journal of cardiology.
[32] James A. White,et al. CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. , 2014, JACC. Cardiovascular imaging.
[33] S. K. White,et al. Native T1 mapping in transthyretin amyloidosis. , 2014, JACC. Cardiovascular imaging.
[34] Subha V Raman,et al. Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping. , 2014, American journal of respiratory and critical care medicine.
[35] D. Pennell,et al. Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy , 2014, Heart.
[36] S. Raman,et al. Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function , 2013, Journal of Cardiovascular Magnetic Resonance.
[37] Amit R. Patel,et al. Atrioventricular heart block and syncope coincident with diagnosis of systemic lupus erythematosus. , 2013, The Canadian journal of cardiology.
[38] R. Kwong,et al. Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients , 2013, Journal of Cardiovascular Magnetic Resonance.
[39] Richard B. Thompson,et al. T1 Mapping With Cardiovascular MRI Is Highly Sensitive for Fabry Disease Independent of Hypertrophy and Sex , 2013, Circulation. Cardiovascular imaging.
[40] A. Freeman,et al. Predictors of cardiac sarcoidosis using commonly available cardiac studies. , 2013, The American journal of cardiology.
[41] R. Kwong,et al. T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy , 2013, Circulation. Cardiovascular imaging.
[42] S. K. White,et al. Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.
[43] M. Robson,et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.
[44] Reza Razavi,et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.
[45] U. Kramer,et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. , 2013, JACC. Cardiovascular imaging.
[46] Tevfik F Ismail,et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.
[47] E. Nagel,et al. Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.
[48] A. Flett,et al. Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis: An Equilibrium Contrast Cardiovascular Magnetic Resonance Study , 2013, Circulation. Cardiovascular imaging.
[49] Stefan Neubauer,et al. Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy , 2012, Circulation. Cardiovascular imaging.
[50] L. Mulligan,et al. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. , 2012, Journal of the American College of Cardiology.
[51] Igor Klem,et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation , 2011, Journal of the American College of Cardiology.
[52] D. Bluemke,et al. Trabeculated (non-compacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis , 2012, Journal of Cardiovascular Magnetic Resonance.
[53] P. Sanders,et al. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography. , 2012, European heart journal.
[54] Amit R. Patel,et al. Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study , 2011, European journal of heart failure.
[55] Angelo Auricchio,et al. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[56] M. Friedrich,et al. Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria. , 2011, JACC. Cardiovascular imaging.
[57] P. Kistler,et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. , 2011, Journal of the American College of Cardiology.
[58] P. Sanders,et al. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography , 2011, Journal of Cardiovascular Magnetic Resonance.
[59] G. Aquaro,et al. Myocardial fibrosis in isolated left ventricular non‐compaction and its relation to disease severity , 2011, European journal of heart failure.
[60] D. Berman,et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. , 2011, JACC. Cardiovascular imaging.
[61] Gilbert Habib,et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. , 2010, European heart journal.
[62] Wojciech Zareba,et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.
[63] S. Abbara,et al. Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major , 2010 .
[64] P. Kistler,et al. Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients with Implantable Cardioverter Defibrillators for Primary Prevention of Sudden Cardiac Death , 2010 .
[65] R. Kim,et al. Detection of Myocardial Damage in Patients With Sarcoidosis , 2009, Circulation.
[66] J. Wansapura,et al. Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. , 2009, Journal of the American College of Cardiology.
[67] D J Pennell,et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major , 2009, Circulation.
[68] D. Isenberg,et al. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus , 2008, Annals of the rheumatic diseases.
[69] Matthew W. Darlison,et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[70] S. Colan,et al. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia. , 2008, JACC. Cardiovascular imaging.
[71] Luigi Rega,et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[72] R. Wassmuth,et al. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach , 2008, Lupus.
[73] K. Klingel,et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.
[74] S. Neubauer,et al. Evaluation and management of the cardiac amyloidosis. , 2007, Journal of the American College of Cardiology.
[75] D. Knockaert. Cardiac involvement in systemic inflammatory diseases. , 2007, European heart journal.
[76] P. Elliott,et al. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson–Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa , 2007, Heart.
[77] F. Saremi,et al. Utility of cardiac MRI for diagnosis and post-treatment follow-up of lupus myocarditis , 2007, The International Journal of Cardiovascular Imaging.
[78] S. Caruthers,et al. Occult Cardiac Contractile Dysfunction in Dystrophin-Deficient Children Revealed by Cardiac Magnetic Resonance Strain Imaging , 2005, Circulation.
[79] H. Crijns,et al. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. , 2005, Chest.
[80] Michael Jerosch-Herold,et al. Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.
[81] R. Kim,et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.
[82] Stefan Neubauer,et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.
[83] W. Dassen,et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. , 2005, Journal of the American College of Cardiology.
[84] P. Woodard,et al. Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report , 2005, Lupus.
[85] R. Falk,et al. Cardiovascular magnetic resonance in cardiac amyloidosis. , 2005, Circulation.
[86] Hugh Calkins,et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.
[87] Marvin D Nelson,et al. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. , 2004, Blood.
[88] D. Pennell,et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. , 2003, European heart journal.
[89] C H Lorenz,et al. Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.
[90] D N Firmin,et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.
[91] Kluwer Academic Publishers. The international journal of cardiovascular imaging , 2001 .
[92] Byun,et al. Patients with Systemic Lupus Erythematosus , 1999 .
[93] H. Hishida,et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. , 1999, American heart journal.
[94] G. Hutchins,et al. Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis , 1978, Circulation.
[95] E. Nagel,et al. Mapping in Discrimination of Hypertrophic Phenotypes : Hypertensive Heart Disease and Hypertrophic Cardiomyopathy Findings From the International T 1 Multicenter Cardiovascular Magnetic Resonance Study , 2022 .